Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Current Liabilities (2020 - 2025)

Journey Medical (DERM) has disclosed Total Current Liabilities for 6 consecutive years, with $39.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities rose 19.15% year-over-year to $39.7 million, compared with a TTM value of $39.7 million through Sep 2025, up 19.15%, and an annual FY2024 reading of $35.2 million, down 15.99% over the prior year.
  • Total Current Liabilities was $39.7 million for Q3 2025 at Journey Medical, down from $40.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $76.9 million in Q1 2023 and bottomed at $33.3 million in Q3 2024.
  • Average Total Current Liabilities over 5 years is $50.4 million, with a median of $48.5 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 83.93% in 2021, then plummeted 49.93% in 2024.
  • Year by year, Total Current Liabilities stood at $51.6 million in 2021, then increased by 29.48% to $66.8 million in 2022, then plummeted by 37.35% to $41.9 million in 2023, then fell by 15.99% to $35.2 million in 2024, then grew by 12.91% to $39.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for DERM at $39.7 million in Q3 2025, $40.5 million in Q2 2025, and $40.2 million in Q1 2025.